Microbial diversity in pharmaceutical product recalls and environments

PDA Journal of Pharmaceutical Science and Technology

Volumn 61, Issue 5, 2007, Pages 383-399

  Jimenez, Luis ^a  

^a NONE   (United States)

Author keywords

Microbial contamination; Microbial control; Microbial diversity; Recalls

Indexed keywords

BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; FOOD AND DRUG ADMINISTRATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INSTRUMENT STERILIZATION; MICROBIAL CONTAMINATION; MICROBIAL DIVERSITY; MOULD; NONHUMAN; PSEUDOMONAS; QUALITY CONTROL; RALSTONIA PICKETTII; REVIEW; WATER CONTAMINATION; YEAST;

ASEPSIS; BACTERIA; DRUG AND NARCOTIC CONTROL; DRUG CONTAMINATION; ENVIRONMENT, CONTROLLED; ENVIRONMENTAL MICROBIOLOGY; QUALITY CONTROL; TECHNOLOGY, PHARMACEUTICAL;

EID: 37349108158     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Akers, J. Chapter 5. Technological Advances in Microbial Contamination Control. In Microbiology in Pharmaceutical Manufacturing; Prince, R., Ed.; David Horwood International Publishing, Limited: West Sussex, UK, 2001; pp 125-145.
2. Lowery, S. A. Chapter 9. Designing a Contamination Control Program. In Microbiology in Pharmaceutical Manufacturing; Prince, R., Ed.; David Horwood International Publishing, Limited: West Sussex, UK, 2001; pp 203-266.
3. Jimenez, L. Microbial Contamination Control in the Pharmaceutical Industry; Marcel Dekker Publishers: New York, 2004.
4. Jimenez, L. Chapter 1. Microorganisms in the Environment and Their Relevance to Pharmaceutical Processes. In Microbial Contamination Control in the Pharmaceutical Industry; Jimenez, L., Ed.; Marcel Dekker Publishers: New York, 2004; pp 1-14.
5. Cundell, A. M. Microbial identification strategies in the pharmaceutical industry. PDA J. Pharm. Sci. Technol. 2006, 60, 111-23.
6. Friedman, R. L. Aseptic processing contamination case studies and the pharmaceutical quality system. PDA J. Pharm. Sci. Technol. 2005, 59 (2), 118-126.
7. O'May, G. A.; Allison, D. G.; Gilbert, P. A rapid method for the evaluation of both extrinsic and intrinsic contamination and resulting spoilage of water-in-oil emulsions. J. Appl. Microbiol. 2004, 96 (5), 1124-1132.
8. Jimenez, L. Chapter 2. Microbial Limits. In Microbial Contamination Control in the Pharmaceutical Industry; Jimenez, L., Ed.; Marcel Dekker Publishers: New York, 2004; pp 15-44.
9. www.fda.gov/po/enforceindex/2006enforce.html
10. www.fda.gov/po/enforceindex/2005enforce.html
11. www.fda.gov/po/enforceindex/2004enforce.html
12. www.fda/gov/po/enforceindex/2003enforce.html
13. Marino, G.; Maier, C.; Cundell, A. M. A comparison of the MicroCount Digital System to plate count and membrane filtration methods for the enumeration of microorganisms in water for pharmaceutical purposes. PDA J. Pharm. Sci. Technol. 2000, 54 (3), 172-192.
14. Kawai, M.; Matsutera, E.; Kanda, H.; Yamaguchi, N.; Tani, K.; Nasu, M. 16S ribosomal DNA-based analysis of bacterial diversity in purified water used in pharmaceutical manufacturing processes by PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 2002, 68 (2), 699-704.
15. Kulakov, L. A.; McAlister, M. B.; Ogden, K. L.; Larkin, M. L.; O'Hanlon, J. F. Analysis of bacteria contaminating ultrapure water in industrial systems. Appl. Environ. Microbiol. 2002, 68 (4), 1548-1555.
16. McAlister, M. B.; Kulakov, L. A.; O'Hanlon, J. F.; Larkin, M. J.; Ogden, K. L. Survival and nutritional requirements of three bacteria isolated from ultrapure water. J. Ind. Microbiol. Biotechnol. 2002, 29 (2), 75-82.
17. Kawai, M.; Yamaguchi, N.; Nasu, N. Rapid enumeration of physiologically active bacteria in purified water used in the pharmaceutical manufacturing process. J. Appl. Microbiol. 1999, 86 (3), 496-504.
18. Wallner, G.; Tillman, D.; Haberer, K. Evaluation of the ChemScan System for rapid microbiological analysis of pharmaceutical water. PDA J. Pharm. Sci. Technol. 1999, 53 (2), 70-74.
19. Kawai, M.; Yamagishi, J.; Yamaguchi, N.; Tani, K.; Nasu, M. Bacterial population dynamics and community structure in a pharmaceutical manufacturing water supply system determined by realtime PCR and PCR-denaturing gradient gel electrophoresis. J. Appl. Microbiol. 2004, 97 (6), 1123-1131.
20. Cundell, A. Historical Perspective on Methods Development. In Rapid Microbiological Methods in the Pharmaceutical Industry; Easter, M. C., Ed.; Interpharm/CRC: New York, 2003; pp 9-17.
21. Reboli, A. C.; Koshinski, R.; Arias, K.; Marks-Austin, K.; Stieritz, D.; Stull, T. L. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect. Control Hosp. Epidemiol. 1996, 17 (11), 718-720.
22. Moreira, B. M.; Leobons, M. B.; Pellegrino, F. L.; Santos, M.; Teixeira, L. M.; de Andrade Marques, E.; Sampaio, J. L.; Pessoa-Silva, C. L. Ralstonia pickettii and Burkholderia cepacia complex bloodstream infections related to infusion of contaminated water for injection. J. Hosp. Infect. 2005, 60 (1), 51-55.
23. Jimenez, L.; Smalls, S. Molecular detection of Burkholderia cepacia in toiletries, cosmetic and pharmaceutical raw materials and finished products. J. AOAC Int. 2000, 83, 963-966.
24. Cundell, A. M. Managing the microbiological quality of pharmaceutical excipients. PDA J. Pharm. Sci.Technol. 2005, 59 (6), 381-395.
25. Martinez-Bermudez, A.; Rodriguez-de Lecea, J.; Soto-Esteras, T.; Vazquez-Estevez, C.; Chena-Canete, C. Types of microbial contaminants in pharmaceutical raw materials. Rev. Latinoam. Microbiol. 1991, 33, 2153-2157.
26. de la Rosa, M. C.; Medina, M. R.; Vivar, C. Microbiological quality of pharmaceutical raw materials. Pharm. Acta Helv. 1995, 70 (3), 227-232.
27. de la Rosa, M. C.; Mosso, M. A.; Garcia, M. L.; Plaza, C. Resistance to the antimicrobial agents of bacteria isolated from non-sterile pharmaceuticals. J. Appl. Bacteriol. 1993, 74 (5), 570-577.
28. Martinez Bermudez, A. D.; Rodriguez De Lecea, J.; Martinez Solis, F.; Soto Esteras, T. The microflora of materials for parenteral use. Boll. Chim. Farm. 1983, 122 (3), 123-129.
29. Kwon, H.-S.; Yang, E.-H.; Lee, S.-H.; Yeon, S.-W.; Kang, B.-H.; Kim, T.-Y. Rapid identification of potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA. FEMS Microbiol. Lett. 2005, 250 (1), 55-62.
30. De Clerck, E.; Vanhoutte, T.; Hebb, T.; Geerinck, J.; Devos, J.; De Vos, P. Isolation, characterization, and identification of bacterial contaminants in semifinal gelatin extracts. Appl. Environ. Microbiol. 2004, 70 (6), 3664-3672.
31. Jimenez, L.; Smalls, S.; Scalici, C.; Bosko, Y.; Ignar, R. PCR detection of Salmonella typhimurium in pharmaceutical raw materials and products contaminated with a mixed bacterial culture using the BAX™ system. PDA J. Pharm. Sci. Technol. 2001, 55 (5), 286-289.
32. Jimenez, L.; Smalls, S.; Ignar, R. Use of PCR analysis for rapid detection of low levels of bacterial and mold contamination in pharmaceutical samples. J. Microbiol. Methods 2000, 41 (3), 259-265.
33. Jimenez, L. Chapter 4. Sterility Testing and Sterility Procedures. In Microbial Contamination Control in the Pharmaceutical Industry; Jimenez, L., Ed.; Marcel Dekker Publishers: New York, 2004; pp 77-102.
34. Van Doorne, H.; Van Kampen, B. J.; Van der Lee, R. W.; Rummenie, L.; Van der Veen, A. J.; De Vries, W. J. Industrial manufacture of parenteral products in The Netherlands. A survey of eight years of media fills and sterility testing. PDA J. Pharm. Sci. Technol. 1998, 52 (4), 159-64.
35. Schroeder, H. G. Sterility failure analysis. PDA J. Pharm. Sci. Technol. 2005, 59 (2), 89-95.
36. Baggerman, C.; Kannegieter, L. M. Microbiological contamination of raw materials for large-volume parenterals. Appl. Environ. Microbiol. 1984, 48 (3), 662-664.
37. Hyde, W. Origin of bacteria in the clean room and their growth requirements. PDA J. Pharm. Sci. Technol. 1998, 52 (4), 154-158.
38. Favero, M. S.; Puleo, J. R.; Marshall, J. H.; Oxborrow, G. S. Comparative levels and types of microbial contamination detected in industrial clean rooms. Appl. Microbiol. 1966, 14 (4), 539-551.
39. Venkateswaran, K.; Hattori, N.; La Duc, M. T.; Kern, R. ATP as a biomarker of viable microorganisms in clean room facilities. J. Microbiol. Methods 2003, 52, 367-377.
40. Nagarkar P.; Ravetkar, S. D.; Watve, M. G. Oligophilic bacteria as tools to monitor aseptic pharmaceutical production units. Appl. Environ. Microbiol. 2001, 67 (3), 1371-1374.
41. Nakajima, K.; Nonaka, K.; Yamamoto, K.; Yamaguchi, N.; Tani, K.; Nasu, M. Rapid monitoring of microbial contamination on herbal medicines by fluorescent staining method. Lett. Appl. Microbiol. 2005, 40 (2), 128-132.
42. Studer E.; Candrian, U. Identification and characterization by 16S rDNA analysis of viable bacterial colonies isolated from oral medicines based on inactivated or lysed pathogenic bacteria. Biologicals 2003, 31 (1), 39-43.
43. Jimenez, L. Adenosine triphosphate bioluminescence analysis for rapid screening of microbial contamination in non-sterile pharmaceutical samples. PDA J. Pharm. Sci. Technol. 2004, 58 (3), 159-168.
44. Jimenez, L.; Ignar, R.; D'Aiello, R.; Grech, P. Use of PCR analysis for sterility testing in pharmaceutical environments. Journal of Rapid Methods and Automation in Microbiology 2000, 8 (1), 11-20.
45. Roszak, D. B.; Colwell, R. R. Survival strategies of bacteria in the natural environment. Microbiol. Rev. 1987, 51 (3), 365-379.
46. Oliver, J. D. The viable but nonculturable state in bacteria. J. Microbiol. 2005, 43 (8), 93-100.
47. Feuilloley, M. G. J.; Bourdet, G.; Organge, N. Effect of white pulsed light on Pseudomonas aeruginosa culturability and its endotoxin when present in ampoules for injectables. European Journal of Parenteral and Pharmaceutical Sciences 2006, 11, 37-43.
48. Geftic, S. G.; Heymann, H.; Adair, F. W. Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride. Appl. Environ. Microbiol. 1979, 37 (3), 505-510.
49. Papapetropoulou, M.; Papageorgakopoulou, N. Metabolic and structural changes in Pseudomonas aeruginosa, Achromobacter CDC, and Agrobacterium radiobacter cells injured in parenteral fluids. PDA J. Pharm. Sci. Technol. 1994, 48 (6), 299-303.
50. Sundaram, S.; Mallick, S.; Eisenhuth, J.; Howard, G.; Brandwein, H. Retention of water-borne bacteria by membrane filters. Part II: Scanning electron microscopy (SEM) and fatty acid methyl ester (FAME) characterization of bacterial species recovered downstream of 0.2/0.22 micron rated filters. PDA J. Pharm. Sci. Technol. 2001, 55 (2), 87-113.
51. Lee, S. H.; Lee, S. S.; Kim, C. W. Changes in the cell size of Brevundimonas diminuta using different growth agitation rates. PDA J. Pharm. Sci. Technol. 2002, 56 (2), 99-108.
52. Ramond, B.; Rolland, X.; Planchez, C.; Cornet, P.; Antoni, C.; Drocourt, J. L. Enumeration of total viable microorganisms in an antibiotic raw material using ChemScan solid phase cytometer. PDA J. Pharm. Sci. Technol. 2000, 54 (4) 320-331.
53. Mazzola, P. G.; Martins, A. M.; Penna, T. C. Chemical resistance of the gram-negative bacteria to different sanitizers in a water purification system. BMC Infect. Dis. 2006, 6 (1), 131-139.
54. Zani, F.; Minutello, A.; Maggi, L.; Santi, P.; Mazza, P. Evaluation of preservative effectiveness in pharmaceutical products: the use of a wild strain of Pseudomonas cepacia. J. Appl. Microbiol. 1997, 83 (3), 322-326.
55. Palmieri, M. J.; Carito, S. L.; Meyer, R. F. Comparison of rapid NFT and API 20E with conventional methods for identification of gram-negative nonfermentative bacilli from pharmaceutical and cosmetics. Appl. Environ. Microbiol. 1988, 54 (11), 2838-2841.